Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transport of dust across the Solar System: Constraints on the spatial origin of individual micrometeorites from cosmic-ray exposure.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2024
Same author

The effect of ultrafine WO<sub>3</sub> nanoparticles on the organization of thylakoids enriched in photosystem II and energy transfer in photosystem II complexes.

Microscopy research and technique·2023
Same author

Modern Tools for Modern Brachytherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Detection of multi-class pesticide residues with surface-enhanced Raman spectroscopy.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2021
Same author

Association of the Brain-derived Neurotrophic Factor Val66Met Polymorphism with Body Mass Index, Fasting Glucose Levels and Lipid Status in Adolescents.

Balkan journal of medical genetics : BJMG·2020
Same author

Three cooperative mechanisms required for recovery after brain damage.

Scientific reports·2019

Related Experiment Video

Updated: Jul 8, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

[Early intervention in HIV infection].

M Gotić, Z Rolović, I Elezović

    Srpski Arhiv Za Celokupno Lekarstvo
    |November 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Early zidovudine treatment for HIV infection delays AIDS progression and prolongs symptom-free stages. This intervention significantly impacts long-term outcomes for individuals with human immunodeficiency virus (HIV).

    More Related Videos

    Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    Related Experiment Videos

    Last Updated: Jul 8, 2026

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
    08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    Area of Science:

    • Virology
    • Immunology
    • Clinical Medicine

    Context:

    • Human immunodeficiency virus (HIV) infection naturally progresses to Acquired immunodeficiency syndrome (AIDS) over time.
    • Previous research indicated zidovudine improved survival in advanced HIV disease.
    • Early intervention strategies were explored to delay AIDS onset and extend asymptomatic periods.

    Purpose:

    • To review findings from ACTG 019 and ACTG 016 clinical studies.
    • To evaluate the efficacy of early zidovudine intervention in HIV-infected individuals.
    • To determine if zidovudine delays disease progression and prolongs the symptom-free clinical stage.

    Summary:

    • Long-term follow-up showed similar AIDS progression rates regardless of HIV acquisition route, with ~50% developing AIDS within 10 years.
    • Zidovudine treatment initiated in early HIV infection stages, before AIDS development, reduced disease progression.
    • Studies ACTG 019 and ACTG 016 demonstrated benefits of early zidovudine intervention.

    Impact:

    • Zidovudine's efficacy in early HIV stages led to FDA approval for asymptomatic and symptomatic individuals with CD4 counts <500/mm3.
    • The findings shifted treatment paradigms towards earlier intervention in HIV management.
    • This research significantly improved the long-term prognosis for individuals living with HIV.